deltatrials
Unknown PHASE4 INTERVENTIONAL 2-arm NCT02539277

A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection

A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection: A Double Blind, Double Dummy, Randomized, Controlled Trial

Sponsor: Beijing Hospital of Traditional Chinese Medicine

Conditions Acute Upper Respiratory Infection
Interventions Fufangshuanghua granule Fufangshuanghua granule placebo Jinyebaidu granule Jinyebaidu granule placebo
Updated 6 times since 2017 Last updated: Sep 2, 2015 Started: Dec 31, 2014 Primary completion: Nov 30, 2015 Completion: Nov 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02539277, this PHASE4 trial focuses on Acute Upper Respiratory Infection and remains ongoing. Sponsored by Beijing Hospital of Traditional Chinese Medicine, it has been updated 6 times since 2014, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jan 2017 – ~Sep 2017 · 8 months · monthly snapshotRecruiting~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 20 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

  5. Sep 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

    Status: Recruiting → Unknown Status

▶ Show 1 earlier version

  1. Jan 2017 — Sep 2017 [monthly]

    Recruiting PHASE4

    First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Beijing Hospital of Traditional Chinese Medicine
  • Changchun University of Chinese Medicine
  • China Academy of Chinese Medical Sciences
  • First Affiliated Hospital of Heilongjiang Chinese Medicine University
  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences
  • Guangdong Provincial Hospital of Traditional Chinese Medicine
  • Liaoning University of Traditional Chinese Medicine
  • Shandong University of Traditional Chinese Medicine
Data source: China Academy of Chinese Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations